| ||
| Irish researchers discover breakthrough in lung cancer treatment Irish Central Particular enzymes are known to break down normal cell tissue and inadvertently help cancer cells grow. The Irish scientists targeted an enzyme called ... See all stories on this topic » | ||
| Holman Fenwick Willan > Australian Court of Appeal clarifies the law on causation Linex Legal (press release) (registration) In doing so, it considered a wide range of issues which frequently arise in asbestos-related mesothelioma and lung cancer cases, including issues of ... See all stories on this topic » | ||
| Elsevier Acquires Oncology Journal Portfolio From Cancer Information Group Trading Markets (press release) The specific journal titles are: Clinical Breast Cancer, Clinical Lung Cancer, Clinical Lymphoma Myeloma & Leukemia, Clinical Colorectal Cancer, ... See all stories on this topic » |
| ||
| QGEN, CTIC, APCVZ - Notable Stocks at NASDAQ Healthcare Sector by ... ... and immunological disorders; OPAXIO, a Phase III clinical trial product for the treatment of ovarian, esophageal, and non-small cell lung cancer; and brostallicin, a Phase I/II clinical trials product for the treatment of sarcoma. ... San Jose Ca Stock Hot Tips - http://sanjose.california.stockhottips.com/ | ||
| OXGN, ESRX, DNDN - Stocks in Action at NASDAQ Healthcare Sector by ... The company's products include ZYBRESTAT, which is in FALCON Trial - Phase II randomized controlled study for the treatment of 1st-line non-small cell lung cancer, as well as in Phase II Simon two-stage design study for the treatment of ... Fresno Ca Stock Hot Tips - http://fresno.california.stockhottips.com/ |
| ||
| New to this site. - Discussion - Lung Cancer Survivors Support ... By TXCat; Posted today at 8:13 pm · 0 replies; In Non-small cell lung cancer - Stage I; Shared with the public. 0 Recommendations ... www.inspire.com/groups/lung-cancer.../new-to-this-site-26/ | ||
| Extending the lives of lung cancer patients Non-small cell lung cancer (NSCLC) is the most frequent tumour-related cause of death in the world. According to preliminary data from a phase II trial, ... annualreport.roche.com/.../extending_the_lives_of_lung_canc... | ||
| Synta Pharmaceuticals Announces Ganetespib (STA-9090) Non-small ... Back to 'Synta Pharmaceuticals Announces Ganetespib (STA-9090) Non-small Cell Lung Cancer Phase 2 Interim Results to be ...' Previous Article; Next Article ... article.wn.com/.../Synta_Pharmaceuticals_Announces_Ganetes... | ||
| Revisions to the TNM Staging of Non–Small Cell Lung Cancer - CiteULike Arjun Nair, Maria J. Klusmann, Kirupa H. Jogeesvaran, Sisa Grubnic, Siobhan J. Green, Ioannis Vlahos. Radiographics, Vol. 31, No. 1., pp. 215-238. www.citeulike.org/group/946/article/8750448 |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment